We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Genentech and Ipsen have executed a collaborative R&D agreement to develop
sustained-release formulations of Genentech's recombinant human growth hormone
[somatropin (rDNA origin)].
Altana Pharma has reported data demonstrating that once-daily Alvesco, an inhaled
corticosteroid for the treatment of asthma, is comparable to already-marketed,
twice-daily inhaled corticosteroids, budesonide and fluticasone propionate.
Dynavax Technologies has announced that data from a Phase I clinical trial of
the company's AIC ragweed allergy immunotherapy showed that AIC treatment resulted
in a clinically significant improvement in symptoms and a parallel reduction
in medication usage during the peak ragweed season compared to placebo.
Bioenvision has announced interim results from the ongoing clinical studies
of clofarabine in pediatric and adult acute leukemia trials that confirm clofarabine's
outstanding profile observed in previous studies.
An independent data monitoring committee has reviewed the safety and efficacy
data from Bayer Pharmaceuticals' and Onyx Pharmaceuticals' pivotal Phase III
trial in patients with advanced kidney cancer and has concluded that the trial
met its surrogate endpoint -- resulting in statistically significant longer
progression-free survival in those patients administered BAY 43-9006 versus
those patients administered placebo.
The FDA has approved Sepracor's new drug application for Xopenex HFA (levalbuterol
tartrate) Inhalation Aerosol, a hydrofluoroalkane metered-dose inhaler for the
treatment or prevention of bronchospasm in adults, adolescents and children
4 years of age and older with reversible obstructive airway disease.
Schering-Plough has received FDA approval for Temodar (temozolomide) capsules
for use in combination with radiotherapy for the treatment of adult patients
with newly diagnosed glioblastoma multiforme (GBM), a form of malignant brain
cancer.